Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P01137: Variant p.Cys387Arg

Transforming growth factor beta-1 proprotein
Gene: TGFB1
Feedback?
Variant information Variant position: help 387 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Cysteine (C) to Arginine (R) at position 387 (C387R, p.Cys387Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (C) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In IBDIMDE; loss of TGFB1-mediated activation of SMAD signaling; mutant TGFB1 is not secreted. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 387 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 390 The length of the canonical sequence.
Location on the sequence: help VYYVGRKPKVEQLSNMIVRS C KCS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         VYYVGRKPKVEQLSNMIVRSCKCS

                              VYYVGRKPKVEQLSNMIVRSCKCS

Mouse                         VYYVGRKPKVEQLSNMIVRSCKCS

Rat                           VYYVGRKPKVEQLSNMIVRSCKCS

Pig                           VYYVGRKPKVEQLSNMIVRSCKCS

Bovine                        VYYVGRKPKVEQLSNMIVRSCKCS

Sheep                         VYYVGRKPKVEQLSNMIVRSCKCS

Horse                         VYYVGRKPKVEQLSNMIVRSCKCS

Chicken                       IYYVGRNVRVEQLSNMVVRACKCS

Xenopus laevis                IYYVGRTAKVEQLSNMVVRSCNCS
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 279 – 390 Transforming growth factor beta-1
Disulfide bond 322 – 387
Disulfide bond 326 – 389
Beta strand 373 – 390



Literature citations
Human TGF-beta1 deficiency causes severe inflammatory bowel disease and encephalopathy.
Kotlarz D.; Marquardt B.; Baroey T.; Lee W.S.; Konnikova L.; Hollizeck S.; Magg T.; Lehle A.S.; Walz C.; Borggraefe I.; Hauck F.; Bufler P.; Conca R.; Wall S.M.; Schumacher E.M.; Misceo D.; Frengen E.; Bentsen B.S.; Uhlig H.H.; Hopfner K.P.; Muise A.M.; Snapper S.B.; Stroemme P.; Klein C.;
Nat. Genet. 50:344-348(2018)
Cited for: FUNCTION; SUBCELLULAR LOCATION; INVOLVEMENT IN IBDIMDE; VARIANTS IBDIMDE CYS-45; CYS-110 AND ARG-387; CHARACTERIZATION OF VARIANTS IBDIMDE CYS-45; CYS-110 AND ARG-387;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.